$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

$avrw Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000147793223008419 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$1.122M	$1.015M
YoY Change		-43.11%
Cost Of Revenue	$421.0K	$278.0K
YoY Change		-21.91%
Gross Profit	$701.0K	$737.0K
YoY Change		-48.39%
Gross Profit Margin	62.48%	72.61%
Selling, General & Admin	$1.670M	$2.291M
YoY Change		-36.57%
% of Gross Profit	238.23%	310.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$21.00K	$1.000K
YoY Change
% of Gross Profit	3.0%	0.14%
Operating Expenses	$1.455M	$2.309M
YoY Change		-41.29%
Operating Profit	-$754.0K	-$1.572M
YoY Change		-37.27%
Interest Expense	-$6.000K	$15.00K
YoY Change		150.0%
% of Operating Profit
Other Income/Expense, Net	-$397.0K	-$652.0K
YoY Change		61.79%
Pretax Income	-$21.00K	-$2.224M
YoY Change		-23.55%
Income Tax	$3.000K	$0.00
% Of Pretax Income
Net Earnings	-$24.00K	-$2.224M
YoY Change		-38.1%
Net Earnings / Revenue	-2.14%	-219.11%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	-$0.03
COMMON SHARES
Basic Shares Outstanding	73.20M shares	71.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.00K	$189.0K
YoY Change		-95.75%
Cash & Equivalents	$49.00K	$189.0K
Short-Term Investments
Other Short-Term Assets	$69.00K	$55.00K
YoY Change	18.97%	-5.17%
Inventory	$199.0K	$220.0K
Prepaid Expenses	$33.00K	$6.000K
Receivables	$443.0K	$145.0K
Other Receivables	$979.0K	$1.293M
Total Short-Term Assets	$1.956M	$1.976M
YoY Change	-67.0%	-76.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.000K	$2.000K
YoY Change	0.0%	-33.33%
Goodwill
YoY Change
Intangibles	$227.0K
YoY Change	-6.97%
Long-Term Investments	$264.0K	$411.0K
YoY Change		90.28%
Other Assets	$36.00K	$36.00K
YoY Change		-49.3%
Total Long-Term Assets	$651.0K	$845.0K
YoY Change	-29.7%	-87.41%
TOTAL ASSETS
Total Short-Term Assets	$1.956M	$1.976M
Total Long-Term Assets	$651.0K	$845.0K
Total Assets	$2.607M	$2.821M
YoY Change	-61.96%	-81.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.452M	$1.571M
YoY Change	130.23%	-3.62%
Accrued Expenses	$1.342M	$1.691M
YoY Change	-15.33%	18.17%
Deferred Revenue
YoY Change
Short-Term Debt	$139.0K	$577.0K
YoY Change		-1.87%
Long-Term Debt Due	$8.099M	$7.849M
YoY Change		-21.38%
Total Short-Term Liabilities	$12.49M	$12.79M
YoY Change	-10.21%	-15.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.49M	$12.79M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$12.49M	$12.79M
YoY Change	-10.5%	-15.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.4M	-$123.4M
YoY Change	2.87%	9.37%
Common Stock	$78.00K	$73.00K
YoY Change	9.86%	2.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.886M	-$9.968M
YoY Change
Total Liabilities & Shareholders Equity	$2.607M	$2.821M
YoY Change	-61.96%	-81.15%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$24.00K	-$2.224M
YoY Change		-38.1%
Depreciation, Depletion And Amortization	$21.00K	$1.000K
YoY Change
Cash From Operating Activities	-$524.0K	-$721.0K
YoY Change		-85.34%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$7.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$275.0K	$750.0K
YoY Change		-94.6%
Cash From Investing Activities	$272.0K	$743.0K
YoY Change		-94.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	112.0K	-8.000K
YoY Change		-99.83%
NET CHANGE
Cash From Operating Activities	-524.0K	-721.0K
Cash From Investing Activities	272.0K	743.0K
Cash From Financing Activities	112.0K	-8.000K
Net Change In Cash	-140.0K	14.00K
YoY Change		-99.68%
FREE CASH FLOW
Cash From Operating Activities	-$524.0K	-$721.0K
Capital Expenditures	$3.000K	$7.000K
Free Cash Flow	-$527.0K	-$728.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Depreciation Depreciation	1000	usd
	us-gaap	Depreciation Depreciation	1000	usd
CY2023Q3	curr	Working Capital Deficit WorkingCapitalDeficit	10800000	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	724000	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	495000	usd
	curr	Clawback Expected Gross Profit ClawbackExpectedGrossProfit	8000000.0	usd
CY2023Q3	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	570000	usd
CY2023Q3	curr	Fair Value Of Series A Note FairValueOfSeriesANote	4455000	usd
CY2023Q3	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	3394000	usd
CY2022Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	860000	usd
CY2022Q4	curr	Fair Value Of Series A Note FairValueOfSeriesANote	5221000	usd
CY2022Q4	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	3959000	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9180000	usd
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	71717296	shares
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	69808785	shares
CY2022	curr	Stock Price StockPrice	0.25
	curr	Conversion Price ConversionPrice	1.32
CY2022	curr	Conversion Price ConversionPrice	1.32
CY2022	curr	Interest Rate InterestRate	0.180	pure
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2224000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2909000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3420000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
CY2023Q3	curr	Loss From Disposal Group LossFromDisposalGroup	0	usd
CY2022Q3	curr	Loss From Disposal Group LossFromDisposalGroup	-684000	usd
	curr	Loss From Disposal Group LossFromDisposalGroup	0	usd
	curr	Loss From Disposal Group LossFromDisposalGroup	-6967000	usd
CY2023Q3	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	72231926	shares
CY2022Q3	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	70686677	shares
CY2022Q3	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.04
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.05
	curr	Vested Stock Options From The Companys Equity Incentive Plan VestedStockOptionsFromTheCompanysEquityIncentivePlan	1373946	shares
	curr	Vested Stock Options From The Companys Equity Incentive Plan VestedStockOptionsFromTheCompanysEquityIncentivePlan	3173469	shares
	curr	Warrants Shares WarrantsShares	312500	shares
	curr	Warrants Shares WarrantsShares	615530	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	618327	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	584994	shares
CY2022Q4	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	232000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	145000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	232000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	68000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	207000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	176000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	55000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	58000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	129000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441000	usd
CY2023Q3	curr	Inventory Packaging Components InventoryPackagingComponents	70000	usd
CY2023Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	43	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	78000	usd
CY2022Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	usd
CY2022Q3	curr	Cancellation Of Indebtedness Owed By The Company To Buyer In Amount Equal CancellationOfIndebtednessOwedByTheCompanyToBuyerInAmountEqual	4150000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Price NetCashReceivedFromTheAssetSalesPrice	20000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Forgiveness Of Buyer Advances NetCashReceivedFromTheAssetSalesForgivenessOfBuyerAdvances	-4150000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Holdback Secured Promissory Note NetCashReceivedFromTheAssetSalesHoldbackSecuredPromissoryNote	-2000000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Obligations Assumed By Buyer NetCashReceivedFromTheAssetSalesObligationsAssumedByBuyer	-41000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales Buyers Expense To Be Paid By Seller NetCashReceivedFromTheAssetSalesBuyersExpenseToBePaidBySeller	82000	usd
CY2022Q3	curr	Net Cash Received From The Asset Sales NetCashReceivedFromTheAssetSales	13891000	usd
CY2022Q3	curr	Sales Price For Assets Sold SalesPriceForAssetsSold	20000000	usd
CY2022Q2	curr	Estimated Costs To Sell Charged To Goodwill EstimatedCostsToSellChargedToGoodwill	100000	usd
CY2023Q3	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	0	usd
CY2022Q3	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	0	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	0	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	108	usd
CY2023Q3	curr	Consulting Research Development Incomeassetsheldforsale ConsultingResearchDevelopmentIncomeassetsheldforsale	0	usd
CY2022Q3	curr	Consulting Research Development Incomeassetsheldforsale ConsultingResearchDevelopmentIncomeassetsheldforsale	0	usd
	curr	Consulting Research Development Incomeassetsheldforsale ConsultingResearchDevelopmentIncomeassetsheldforsale	0	usd
	curr	Consulting Research Development Incomeassetsheldforsale ConsultingResearchDevelopmentIncomeassetsheldforsale	58	usd
CY2023Q3	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	0	usd
CY2022Q3	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	0	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	0	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	40	usd
CY2023Q3	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	0	usd
CY2022Q3	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	0	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	0	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	206	usd
CY2023Q3	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	0	usd
CY2022Q3	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	0	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	0	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	75	usd
CY2023Q3	curr	Gross Profit Loss GrossProfitLoss	0	usd
	curr	Gross Profit Loss GrossProfitLoss	131	usd
CY2023Q3	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	0	usd
CY2022Q3	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	28	usd
CY2022Q3	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	4728	usd
CY2023Q3	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	0	usd
CY2022Q3	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	684	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	0	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	7098	usd
CY2023Q3	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	0	usd
CY2022Q3	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-684	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	0	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-6967	usd
CY2023Q3	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2022Q3	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2023Q3	curr	Net Loss NetLoss	0	usd
CY2022Q3	curr	Net Loss NetLoss	-684	usd
	curr	Net Loss NetLoss	0	usd
	curr	Net Loss NetLoss	-6967	usd
CY2023Q3	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	6000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	4000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	1000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	19000	usd
CY2022Q4	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2023Q3	curr	Less Current Portion Of Notes Receivable LessCurrentPortionOfNotesReceivable	-1250000	usd
CY2022Q4	curr	Less Current Portion Of Notes Receivable LessCurrentPortionOfNotesReceivable	-2000000	usd
CY2022Q4	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	0	usd
CY2023Q3	curr	Notes Receivable Net Of Current Portion NotesReceivableNetOfCurrentPortion	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	406000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-91000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	317000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	20000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	68000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	34000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	17000	usd
CY2023Q3	curr	Investment In Biopharmaceutical Research Company InvestmentInBiopharmaceuticalResearchCompany	213000	usd
CY2023Q3	us-gaap	Investments Investments	411000	usd
CY2022Q4	us-gaap	Investments Investments	411000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	421000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	421000	usd
CY2023Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	542000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	551000	usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	266000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	233000	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	146000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	82000	usd
CY2023Q3	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	89000	usd
CY2022Q4	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	64000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	304000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	217000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	344000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	331000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1691000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1478000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	33000	usd
	curr	Interest Expense To Related Party Payables InterestExpenseToRelatedPartyPayables	111000	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	27000	usd
CY2022Q4	curr	Loan Payable Less Current Portion LoanPayableLessCurrentPortion	0	usd
CY2023Q3	curr	Loan Payable Less Current Portion LoanPayableLessCurrentPortion	0	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	161000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	11000	usd
CY2023Q3	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	11000	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	11000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	33000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	5221000	usd
CY2023Q3	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	3394000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	3959000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7849000	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2020	curr	Remaining Balance Of Investor Note Amount RemainingBalanceOfInvestorNoteAmount	5000000.0	usd
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.18	pure
	curr	Description Of Debt Settlement DescriptionOfDebtSettlement	If the Company is required to settle the Series A and B Notes under those terms, the settlement would be either (i) a cash payment of approximately $8.1 million, or (ii) the issuance of 3,765,561 shares of the Company’s common stock plus a cash payment of approximately $7.8 million, at the option of the Investor
	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2023Q3	curr	Right Of Use Lease Liabilities Noncurrent RightOfUseLeaseLiabilitiesNoncurrent	0	usd
CY2022Q4	curr	Right Of Use Lease Liabilities Noncurrent RightOfUseLeaseLiabilitiesNoncurrent	46000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	78000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	170000	usd
	curr	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P0Y6M29D
CY2022	curr	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P1Y3M14D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2023Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	31000	usd
CY2022Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	30000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	92000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	91000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	35000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	46000	usd
CY2023Q3	curr	Lessor Operating Lease Payments Undiscounted Cash Flow LessorOperatingLeasePaymentsUndiscountedCashFlow	81000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	3000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	78000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160000	usd
CY2023Q3	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	78000	usd
	curr	Disposal Group Per Share DisposalGroupPerShare	-0.10
	dei	Entity Central Index Key EntityCentralIndexKey	0001643301
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Security12g Title Security12gTitle	Common stock, par value $0.001
	dei	Trading Symbol TradingSymbol	AVRW
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73195429	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71426801	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55908
	dei	Entity Registrant Name EntityRegistrantName	AVENIR WELLNESS SOLUTIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1504639
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5805 Sepulveda Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 801
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sherman Oaks
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91411
	dei	City Area Code CityAreaCode	424
	dei	Local Phone Number LocalPhoneNumber	273-8675
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73202929	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	189000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2943000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	145000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	232000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	220000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	145000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	129000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441000	usd
CY2023Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	1250000	usd
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	2000000	usd
CY2023Q3	curr	Related Party Transaction Due From Related Party Current RelatedPartyTransactionDueFromRelatedPartyCurrent	43000	usd
CY2022Q4	curr	Related Party Transaction Due From Related Party Current RelatedPartyTransactionDueFromRelatedPartyCurrent	167000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1976000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5928000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160000	usd
CY2023Q3	us-gaap	Investments Investments	411000	usd
CY2022Q4	us-gaap	Investments Investments	411000	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	317000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	315000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	36000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	36000	usd
CY2023Q3	us-gaap	Assets Assets	2821000	usd
CY2022Q4	us-gaap	Assets Assets	6854000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1571000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1065000	usd
CY2023Q3	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1691000	usd
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	1478000	usd
CY2023Q3	curr	Operating Lease Liabilitycurrent OperatingLeaseLiabilitycurrent	78000	usd
CY2022Q4	curr	Operating Lease Liabilitycurrent OperatingLeaseLiabilitycurrent	124000	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	27000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	161000	usd
CY2023Q3	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2023Q3	curr	Fair Value Of Convertible Promissory Notes FairValueOfConvertiblePromissoryNotes	7849000	usd
CY2022Q4	curr	Fair Value Of Convertible Promissory Notes FairValueOfConvertiblePromissoryNotes	9180000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	453000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	495000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	570000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	860000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12789000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13913000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12789000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13959000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73195429	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71426801	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	73000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	113026000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	112471000	usd
CY2023Q3	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	308000	usd
CY2022Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	308000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123375000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119955000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-9968000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7105000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2821000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6854000	usd
CY2023Q3	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	1015000	usd
CY2022Q3	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	1784000	usd
	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	3225000	usd
	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	3983000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	278000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	356000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	817000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	843000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	737000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1428000	usd
	us-gaap	Gross Profit GrossProfit	2408000	usd
	us-gaap	Gross Profit GrossProfit	3140000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2291000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3610000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7450000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9454000	usd
CY2023Q3	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	18000	usd
CY2022Q3	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	322000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-290000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-513000	usd
CY2023Q3	curr	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
CY2022Q3	curr	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
	curr	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
	curr	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	4622000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2309000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	3932000	usd
	us-gaap	Operating Expenses OperatingExpenses	7160000	usd
	us-gaap	Operating Expenses OperatingExpenses	13563000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1572000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2504000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4752000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10423000	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	11000	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	14000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	43000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	17000	usd
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	82000	usd
CY2023Q3	curr	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	0	usd
CY2022Q3	curr	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	0	usd
	curr	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	0	usd
	curr	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	40000	usd
CY2023Q3	curr	Adjustment Of Fair Value Of Convertible Promissory Notes AdjustmentOfFairValueOfConvertiblePromissoryNotes	-648000	usd
CY2022Q3	curr	Adjustment Of Fair Value Of Convertible Promissory Notes AdjustmentOfFairValueOfConvertiblePromissoryNotes	-411000	usd
	curr	Adjustment Of Fair Value Of Convertible Promissory Notes AdjustmentOfFairValueOfConvertiblePromissoryNotes	1331000	usd
	curr	Adjustment Of Fair Value Of Convertible Promissory Notes AdjustmentOfFairValueOfConvertiblePromissoryNotes	-718000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	8000	usd
	us-gaap	Interest Expense InterestExpense	42000	usd
	us-gaap	Interest Expense InterestExpense	420000	usd
CY2023Q3	us-gaap	Other Income OtherIncome	0	usd
CY2022Q3	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	26000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-652000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-405000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1332000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-973000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2224000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2909000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3420000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11396000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2224000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2909000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3420000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
CY2023Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-119000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-6402000	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-565000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-565000	usd
CY2023Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2022Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0	usd
CY2023Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	usd
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-684000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	0	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-6967000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2224000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3593000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3420000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18363000	usd
CY2023Q3	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.03
CY2022Q3	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.04
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.05
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.16
CY2023Q3	curr	Disposal Shares Group DisposalSharesGroup	0
CY2022Q3	curr	Disposal Shares Group DisposalSharesGroup	-0.01
	curr	Disposal Shares Group DisposalSharesGroup	0
	curr	Disposal Shares Group DisposalSharesGroup	-0.10
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7105000	usd
CY2023Q1	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	2000	usd
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.26
CY2023Q3	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	72231926	shares
CY2022Q3	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	70686677	shares
	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	71717296	shares
	curr	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	69808785	shares
CY2023Q1	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	96000	usd
CY2023Q1	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	113000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-209000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7103000	usd
CY2023Q2	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	32000	usd
CY2023Q2	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	75000	usd
CY2023Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	115000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-987000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-7868000	usd
CY2023Q3	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	9000	usd
CY2023Q3	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	72000	usd
CY2023Q3	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	43000	usd
CY2023Q3	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2224000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-9968000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022Q1	curr	Issuance Of Common Stock For Professional Services IssuanceOfCommonStockForProfessionalServices	17000	usd
CY2022Q1	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	666000	usd
CY2022Q1	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	352000	usd
CY2022Q1	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	103000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5151000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12099000	usd
CY2022Q2	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	-10000	usd
CY2022Q2	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	316000	usd
CY2022Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	102000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9619000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2888000	usd
CY2022Q3	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	241000	usd
CY2022Q3	curr	Fair Value Of Stock Options Granted FairValueOfStockOptionsGranted	189000	usd
CY2022Q3	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	102000	usd
CY2022Q3	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3593000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-173000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3420000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11396000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	6967000	usd
	us-gaap	Profit Loss ProfitLoss	3420000	usd
	us-gaap	Profit Loss ProfitLoss	18363000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	0	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	565000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	43000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7000	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	0	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	40000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	290000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	513000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	1331000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-718000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4622000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1390000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	81000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	71000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4443000	usd
	us-gaap	Interest Paid InterestPaid	9000	usd
	us-gaap	Interest Paid InterestPaid	585000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-35000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	84000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	-108000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	514000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	1405000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	87000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	127000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-312000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	46000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	104000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-124000	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	248000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-506000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1178000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-213000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2012000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	92000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	79000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	42000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	-95000	usd
	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	0	usd
	us-gaap	Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities	5112000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3319000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8487000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	750000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	13891000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	699000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13891000	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	0	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	200000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3702000	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	0	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	2629000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	190000	usd
	curr	Reclassification Of Accrued Expense To Related Party Payable ReclassificationOfAccruedExpenseToRelatedPartyPayable	0	usd
	curr	Reclassification Of Accrued Expense To Related Party Payable ReclassificationOfAccruedExpenseToRelatedPartyPayable	-2243000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	38000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	134000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	235000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-134000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-977000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2754000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4427000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2943000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	189000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	curr	Non Cash Cancellation Of Indebtedness To Buyer Of Assets Sold NonCashCancellationOfIndebtednessToBuyerOfAssetsSold	0	usd
	curr	Non Cash Cancellation Of Indebtedness To Buyer Of Assets Sold NonCashCancellationOfIndebtednessToBuyerOfAssetsSold	4150000	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	0	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	2000000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	666000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	42000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The accompanying unaudited interim condensed consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to prevent the information presented from being misleading. These financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K, which contains audited financial information for the two years in the period ended December 31, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of ordinary recurring items) to present fairly the financial position and the results of operations of the Company for the periods presented. Interim results are not necessarily indicative of results to be expected for the full fiscal year or any future period. </p>
CY2023Q3	us-gaap	Cash Cash	189000	usd
CY2023Q3	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	123400000	usd
	us-gaap	Reclassifications Reclassifications	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Certain reclassifications have been made to prior year’s consolidated financial statements to enhance comparability with the current year’s consolidated financial statements. These reclassifications had no effect on the previously reported net loss.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of certain macroeconomic factors, including inflation, rising interest rates, and recessionary pressures, on its business and operations. Although the full impact of these factors is unknown and cannot be estimated reasonably, the Company believes it has made appropriate accounting estimates and assumptions based on the facts and circumstances available as of the reporting date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Significant areas requiring the use of management estimates include, but are not limited to, revenue recognition, the allowance for doubtful accounts, valuation of intangible assets and goodwill, depreciation and amortization useful lives, assumptions used to calculate the fair value of the contingent stock consideration, stock-based compensation, deferred taxes and the assumptions used to calculate fair values of the purchase price allocations and convertible promissory notes. Actual results could differ materially from such estimates under different assumptions or circumstances.</p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	curr	Deferred Revenuepolicytextblock DeferredRevenuepolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Advance payments and billings in excess of revenue recognized represents deferred revenue and is recorded as a liability when customers remit cash payments in advance before the Company satisfies its performance obligations under contractual or other sales arrangements. Deferred revenue is derecognized when revenue is recognized and the performance obligation is satisfied and is generally classified as current based on the timing of when the Company expects to recognize the revenue. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Deferred revenue is made up of the following as of September 30, 2023 and December 31, 2022 (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Advance payments and customer deposits for commercial products</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">453</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">495</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The following table summarizes the changes in deferred revenue during the period presented (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">495</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Customer deposits returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Transfers to revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(107 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at September 30, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">453</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	curr	Contingent Consideration Liabilitiespolicytextblock ContingentConsiderationLiabilitiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Certain of the Company’s business acquisitions involve the potential for future payment of consideration to former selling security holders in amounts determined upon the attainment of revenue and gross margin milestones from product sales. The fair value of such liabilities is determined using unobservable inputs. These inputs include the estimated amount and timing of projected cash flows and the risk-adjusted discount rate used to present value the cash flows. These obligations are referred to as contingent consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">ASC 805, “Business Combinations,” requires that contingent consideration be estimated and recorded at fair value as of the acquisition date as part of the total consideration transferred. Additionally, the fair value of contingent consideration after the acquisition date is reassessed by the Company as changes in circumstances and conditions occur, with the subsequent change in fair value recorded in its unaudited condensed consolidated statements of operations. Changes in key assumptions can materially affect the estimated fair value of contingent consideration liabilities. See Note 18 – Contingent Stock Consideration for additional information.</p>
	curr	Practical Expedients And Exemptionspolicytextblock PracticalExpedientsAndExemptionspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company has elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company made the accounting policy election to exclude any sales and similar taxes from the transaction price; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the Company adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</p></td></tr></tbody></table>
	curr	Sales Taxpolicytextblock SalesTaxpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to a customer, excluding sales taxes. The net amount of sales tax payable to the various state taxation authorities is included in sales tax payable in the unaudited condensed consolidated balance sheets.</p>
	curr	Sales Returns Discounts And Warrantiespolicytextblock SalesReturnsDiscountsAndWarrantiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Sales returns, discount and warranties are considered variable consideration under ASC 606. The Company reduces revenue for estimated future returns, discounts and warranties which may occur with distributors and retailers. When evaluating the adequacy of sales returns, discounts and warranties, the Company analyzes the following: historical credit allowances, current sell-through of inventory of the Company’s products, current trends in retail industry, changes in customer demand, acceptance of products, and other related factors.</p>
	curr	Cost To Obtain A Contractpolicytextblock CostToObtainAContractpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Company pays sales commissions to its employees and outside sales representatives for contracts and orders that they obtain relating to the wholesale sales of our products. The Company applies the optional practical expedient to immediately expense costs to obtain a contract or order if the recognition period of the revenue is one year or less. As such, sales commissions are immediately recognized as an expense and included as part of sales and marketing expenses.</p>
CY2023Q3	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	453000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	495000	usd
	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	65000	usd
	curr	Contract Liabilities Customer Deposits Returned ContractLiabilitiesCustomerDepositsReturned	0	usd
	curr	Contract Liabilities Transfers To Revenue ContractLiabilitiesTransfersToRevenue	-107000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	453000	usd
	curr	Cost Of Goods Soldpolicytextblock CostOfGoodsSoldpolicytextblock	<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:33.75pt">Cost of goods sold primarily consists of costs for our products incurred to third-party manufacturers and in-bound freight.</p>
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	834000	usd
	us-gaap	Advertising Expense AdvertisingExpense	2300000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1400	usd
CY2023Q3	curr	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2022Q4	curr	Value Of Stock Earn Out Payment In Clawback Period ValueOfStockEarnOutPaymentInClawbackPeriod	0	usd
CY2022Q4	curr	Earn Out Stock Value EarnOutStockValue	720	usd
	curr	Changes In Fair Value Of Series A Note ChangesInFairValueOfSeriesANote	-766000	usd
	curr	Change In Fair Value Of Series B Notes ChangeInFairValueOfSeriesBNotes	-565000	usd
CY2023Q3	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	7849000	usd
	curr	Stock Price StockPrice	0.25
	curr	Interest Rate InterestRate	0.180	pure
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2224000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3593000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3420000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18363000	usd
CY2023Q3	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.03
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.16
	curr	Disposal Group Per Share DisposalGroupPerShare	0
CY2022Q3	curr	Disposal Group Per Share DisposalGroupPerShare	-0.01
CY2023Q3	curr	Disposal Group Per Share DisposalGroupPerShare	0
	curr	Anti Dilutive Shares AntiDilutiveShares	2304773	shares
	curr	Anti Dilutive Shares AntiDilutiveShares	4373993	shares
CY2023Q3	curr	Maximum Share Receivale Upon Achievement Of Certain Sales Milestones MaximumShareReceivaleUponAchievementOfCertainSalesMilestones	5988024	shares
	curr	Common Stock Conversion Price CommonStockConversionPrice	1.32
CY2023Q3	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	145000	usd
CY2022Q4	curr	Inventory Packaging Components InventoryPackagingComponents	88000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	429000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	420000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	499000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	508000	usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments	-279000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	-363000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	220000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	145000	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	usd
CY2022Q3	curr	Consideration Paid For Asset Sale ConsiderationPaidForAssetSale	20000000.0	usd
CY2022Q3	curr	Net Book Value Of Assets Sold NetBookValueOfAssetsSold	20616000	usd
CY2022Q3	curr	Net Book Value Of Liabilities Sold NetBookValueOfLiabilitiesSold	-51000	usd
CY2022Q3	curr	Net Book Value Of Net Assets Sold NetBookValueOfNetAssetsSold	20565000	usd
CY2022Q3	curr	Gain Loss On Sale Of Net Assets GainLossOnSaleOfNetAssets	-565000	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	20600000	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	4000000.0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	3400000	usd
	curr	Additional Impairment Loss AdditionalImpairmentLoss	2000000.0	usd
CY2022Q3	curr	Gross Profit Loss GrossProfitLoss	0	usd
	curr	Gross Profit Loss GrossProfitLoss	0	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	0	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	492	usd
CY2023Q3	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	0	usd
CY2022Q3	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	91	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	0	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	1313	usd
CY2023Q3	curr	Loss On Dispositionassetsheldforsale LossOnDispositionassetsheldforsale	0	usd
CY2022Q3	curr	Loss On Dispositionassetsheldforsale LossOnDispositionassetsheldforsale	565	usd
	curr	Loss On Dispositionassetsheldforsale LossOnDispositionassetsheldforsale	0	usd
	curr	Loss On Dispositionassetsheldforsale LossOnDispositionassetsheldforsale	565	usd
CY2023Q3	curr	Impairment Of Goodwill Assets Held For Sale ImpairmentOfGoodwillAssetsHeldForSale	0	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1000	usd
CY2023Q3	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	457000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-140000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	315000	usd
CY2022Q3	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	4600000	usd
CY2022	curr	Other Asset Impairments Charges OtherAssetImpairmentsCharges	4700000	usd
CY2021	curr	Other Asset Impairments Charges OtherAssetImpairmentsCharges	1100000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4600000	usd
CY2023Q3	us-gaap	Exploration Expense ExplorationExpense	20000	usd
CY2022Q3	us-gaap	Exploration Expense ExplorationExpense	223000	usd
	us-gaap	Exploration Expense ExplorationExpense	49000	usd
	us-gaap	Exploration Expense ExplorationExpense	1400000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	19000	usd
CY2023Q3	curr	Finite Lived Intangible Assets Amortization Expense Rolling Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseRollingThereafter	140000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	317000	usd
CY2022Q4	curr	Investment In Biopharmaceutical Research Company InvestmentInBiopharmaceuticalResearchCompany	213000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	153	usd
	curr	Goods And Services Purchased GoodsAndServicesPurchased	149000	usd
	curr	Interest Expense To Related Party Payables InterestExpenseToRelatedPartyPayables	0	usd
	curr	Scheduleoffair Value Of Convertible Promissory Notes Tabletextblock ScheduleoffairValueOfConvertiblePromissoryNotesTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series A subordinated convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,455</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,221</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series B senior secured convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,394</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,959</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Carrying value of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,849</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,180</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less: current portion of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(7,849 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(9,180 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Convertible promissory notes at fair value, less current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q3	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	4455000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9180000	usd
CY2023Q3	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-7849000	usd
CY2022Q4	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9180000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	curr	Aggregate Common Stock Shares Issued During Period AggregateCommonStockSharesIssuedDuringPeriod	1665000	shares
	curr	Share Based Compensation Arrangement By Share Based Payment Number Of Awards Outstanding ShareBasedCompensationArrangementByShareBasedPaymentNumberOfAwardsOutstanding	3154139	shares
	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Remaining Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageRemainingContractualLifeYears	P7Y3M18D
	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePrice	1.20
	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	1373946	shares
	curr	Share Based Compensation Arrangement By Share Based Payment Awards Weighted Average Exercise Price Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardsWeightedAverageExercisePriceExercisable	1.33
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1192369	shares
	curr	Common Stock Issued During Period Price Per Share CommonStockIssuedDuringPeriodPricePerShare	0.19
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	225000	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	150000	shares
	curr	Common Stock Issued During Period Price Per Share CommonStockIssuedDuringPeriodPricePerShare	2.05
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	308000	usd
CY2020Q4	curr	Payment Of Upfront Payment In Cash PaymentOfUpfrontPaymentInCash	1000000.0	usd
CY2020Q4	curr	Closing Merger Consideration Shares ClosingMergerConsiderationShares	5014868	shares
CY2020Q4	curr	Potential Shares To Be Issued During Period PotentialSharesToBeIssuedDuringPeriod	5988024	shares
CY2023Q3	curr	Earned Shares EarnedShares	4491018	shares
CY2023Q3	curr	Additional Shares Earned AdditionalSharesEarned	1497006	shares
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	860000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	290000	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	570000	usd
	us-gaap	Payments For Rent PaymentsForRent	10000	usd
CY2023Q3	curr	Monthly Base Rent Percentagea MonthlyBaseRentPercentagea	0.03	pure
CY2022Q4	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	124000	usd

Files In Submission

Name	View Source	Status
0001477932-23-008419-index-headers.html	Edgar Link	pending
0001477932-23-008419-index.html	Edgar Link	pending
0001477932-23-008419.txt	Edgar Link	pending
0001477932-23-008419-xbrl.zip	Edgar Link	pending
avrw_10q.htm	Edgar Link	pending
avrw_ex311.htm	Edgar Link	pending
avrw_ex312.htm	Edgar Link	pending
avrw_ex321.htm	Edgar Link	pending
avrw_ex322.htm	Edgar Link	pending
curr-20230930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
avrw_10q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
curr-20230930_cal.xml	Edgar Link	unprocessable
curr-20230930_def.xml	Edgar Link	unprocessable
curr-20230930_lab.xml	Edgar Link	unprocessable
curr-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

2023 Q4 Form 10-Q Financial Statement

#000147793223008419 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW Avenir Wellness Solutions, Inc. Stock $avrw

2023 Q4 Form 10-Q Financial Statement

#000147793223008419 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw